Doctor Evidence Announces the Appointment of Michael J. Klag, MD, MPH to its Medical Strategy Advisory Board

January 27, 2021

January 27, 2021 10:00 AM Eastern Standard Time SANTA MONICA, Calif.–(BUSINESS WIRE)–Doctor Evidence is pleased to announce the appointment of Michael J. Klag, MD, MPH to the MSAB. He joins Chair, Ameet Nathwani, MD, MRCP, DipPharmMed, MBA and members Calum MacRae, MB, ChB, PhD, BSc, Frank Rockhold, PhD, ScM, BA, and David Tovey, MD. Dr. […]

Read More

Doctor Evidence (DRE) and The Castleman Disease Collaborative Network (CDCN) Announce Collaboration

December 16, 2020

DRE will work with David C. Fajgenbaum, MD, MBA, MSc, and his team of researchers to use DRE software platforms for the COvid19 Registry of Off-label and New Agents (CORONA), in identifying and analyzing all COVID-19 treatments to prioritize clinical trials and support physicians in providing the best possible care for their patients with COVID-19 December 16, 2020, 10:00 AM […]

Read More

Doctor Evidence (“DRE”) Named Member of The Trinity Challenge

November 10, 2020

AI-driven healthcare technology leader selected to participate in global initiative to better protect the world against health emergencies SANTA MONICA, Calif.–(BUSINESS WIRE)–DRE announced today that it has been selected as a Member of The Trinity Challenge. The Trinity Challenge was launched in September 2020 by Dame Sally Davies, the Master of Trinity College, Cambridge, and former […]

Read More

Doctor Evidence, LLC (“DRE”) Expands Medical Strategy Advisory Board to Strengthen its Artificial Intelligence Solution in Drug Discovery

October 19, 2020

Medical Strategy Advisory Board (“MSAB”) to advise DRE on the convergence of expert AI-enabled technology in healthcare and the exponential growth of clinical information October 19, 2020 10:00 AM Eastern Daylight Time SANTA MONICA, Calif.–(BUSINESS WIRE)–DRE is pleased to welcome four new members to its MSAB. They join Chair, Ameet Nathwani, MD, MRCP, DipPharmMed, MBA […]

Read More

Doctor Evidence to Deploy Its AI-Enabled SaaS DOC Search™ and DOC Analytics™ Platform for COVID-19 to Accelerate Drug Discovery

July 14, 2020

SANTA MONICA, Calif.–(BUSINESS WIRE)–Doctor Evidence (“DRE”) has developed new tools for automated network meta-analysis, to now be used in the hunt for the most effective treatments for COVID-19. Clinical trial data is continuously emerging that can now be aggregated in real time using DRE’s DOC Analytics™ platform. Read more…

Read More

DRE’s DOC Analytics™ Generates First-Ever Automated Network Meta-Analysis with Natural Language Question AI-Powered Search Results

June 10, 2020

SANTA MONICA, Calif.–(BUSINESS WIRE)–Doctor Evidence (DRE) has updated their newly launched DOC Analytics™ (“Digital Outcome Conversion”) platform with industry standard network meta-analysis (NMA) capabilities. DOC Analytics™ provides immediate quantitative insights into the universe of medical information using artificial intelligence/machine learning (AI/ML) and natural language processing (NLP). With the addition of indirect treatment comparison and landscape analysis using NMA, DOC Analytics™ is a […]

Read More

Dr Evidence (DRE), an AI-Enabled SaaS Healthcare Insights Company, Taps Industry Experts Joseph A. Boystak as Chairman of the Board and Ameet Nathwani, MD, as Chairman of its Newly Formed Medical Strategy Advisory Board

June 2, 2020

SANTA MONICA, Calif.–(BUSINESS WIRE)–DRE is pleased to welcome Joe Boystak as Chairman of the Board and Ameet Nathwani, MD, as Chairman of its newly formed Medical Strategy Advisory Board (MSAB). These enhancements to the Company reflect the expanded need for keen guidance in this unprecedented time of convergence between expert AI-enabled technology in healthcare and […]

Read More

Doctor Evidence’s newly released DOC Analytics™ performs rapid network meta-analyses to generate real-time insights using natural language processing and rigorous methodology

May 19, 2020

SANTA MONICA, Calif., May 19, 2020 /PRNewswire/ — Doctor Evidence (DRE), a leading Artificial Intelligence-powered SaaS healthcare insights company, has launched its revolutionary DOC (“Digital Outcome Conversion”) Analytics™ platform. DOC Analytics™ is a culmination of over 10-years of R&D and product development.  In DOC Analytics™, users can ask natural language medical questions and get precise search results that are powered by DRE’s DOC […]

Read More

Response to the Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset made available to Academic Researchers

March 17, 2020

SANTA MONICA, Calif., March 17, 2020 /PRNewswire/ — Doctor Evidence (“DRE”) is focusing its AI-enabled  medical search engine on the COVID-19 medical literature and daily emerging breaking research. Today, as requested by The White House Office of Science and Technology Policy and in response to researchers call for AI machine-readable technology to address the fast evolving Coronavirus literature, […]

Read More

Doctor Evidence is Empowering Researchers with an Intuitive AI Solution for Rapid Literature Review and Surveillance – Updates to a User-Friendly Interface in DOC Search

January 19, 2020

SANTA MONICA, Calif., June 19, 2019 /PRNewswire/ — Doctor Evidence, a global health technology and consulting company in biomedical research, releases new updates and an interactive user interface for the DOC Search platform on June 24th. DOC Search was designed to empower both novice and experienced researchers with a user-friendly turnkey solution to independently conduct rapid literature reviews and […]

Read More


January 15, 2020

Doctor Evidence and Pharmaspectra have formed an alliance where Pharmaspectra’s datahub, Insightmeme® global Congress data captured from monitoring over 18,000 meetings per year will be offered in Doctor Evidence’s powerful search platform, DOC Search®. Read More

Read More

Doctor Evidence is Training AI-Based Technology to Distinguish Real-World Evidence in Literature Search and Monitoring

June 16, 2019

SANTA MONICA, Calif., June 3, 2019 /PRNewswire/ — Doctor Evidence (DRE), a global health technology and healthcare research consulting company, continues to breakthrough artificial intelligence (AI) hurdles with the ability to auto-identify research studies that are based on real-world evidence (RWE). Yesterday, at the AcademyHealth Annual Research Meeting in Washington DC, DRE presented a poster entitled, […]

Read More

Doctor Evidence CEO Awarded Two Honorary Fellowships

November 27, 2018

SANTA MONICA, Calif., Nov. 27, 2018 /PRNewswire/ — Robert Battista was recently selected for fellowship in the Royal College of Physicians of Edinburgh and the Royal Society for Public Health. Doctor Evidence announces the awarding of two honorary fellowships to Robert Battista, the CEO and co-founder, in recognition for his innovative work in healthcare. The Royal College of Physicians […]

Read More

Doctor Evidence Conducted Systematic Evidence Review for Leading Cardiology Societies for Bradycardia Guideline Evidence Review and Analyses

November 6, 2018

SANTA MONICA, Calif., Nov. 6, 2018 /PRNewswire/ –Systematic reviews of clinical research were conducted with Doctor Evidence technologies and services to support evidence-based guidelines on abnormally slow heart rates by the American College of Cardiology, American Heart Association, and Heart Rhythm Society Today, the American College of Cardiology (ACC), American Heart Association (AHA), and Heart […]

Read More

Connecting Published Data To Real World Evidence: What’s The DIF (Data Impact Factor)

November 5, 2018

SANTA MONICA, CA (PRWEB) Nov. 5, 2018– Doctor Evidence has launched DIF—the Data Impact Factor—technology for identifying data cohorts, across time and various reported data sets.  As technology progresses, it has become possible to move from past paradigms, like the Journal Impact Factor, which is an index of the relative influence of leading journals. Today’s […]

Read More

The American Society Of Hematology To Make Its Meeting Abstracts Available In Leading Artificial Intelligence Technology Platform

October 26, 2018

WASHINGTON, Oct. 26, 2018 /PRNewswire/ — The American Society of Hematology (ASH), has entered into an agreement with Doctor Evidence (DRE) to host ASH annual meeting abstracts in DRE’s innovative DOC Search artificial intelligence technology platform. ASH is the world’s largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases. Read […]

Read More

American Thoracic Society publishes guideline on malignant pleural effusions; Doctor Evidence collaborated on the underlying meta-analysis

October 1, 2018

New Guideline Recommends Minimally Invasive Ways of Treating Malignant Pleural Effusions Oct. 1, 2018─A new guideline to help clinicians manage malignant pleural effusions (MPEs) has been developed by the American Thoracic Society, the Society of Thoracic Surgeons and the Society of Thoracic Radiology.  The clinical practice guideline is published online in the Oct. 1 American Journal of Respiratory […]

Read More

Doctor Evidence collaborated on the underlying systematic review for new guideline published by leading oncology association

February 14, 2018

SANTA MONICA, CA (PRWEB) Feb 14, 2018-Guideline addresses the management of side effects from immune checkpoint inhibitors treatments Doctor Evidence (DRE), a global health technology and data company, is proud to have performed the systematic review of evidence, through the GROWTH program, in support of a new guideline issued by the American Society of Clinical […]

Read More

American College of Chest Physicians publishes new lung cancer screening guidelines

January 29, 2018

SANTA MONICA, CA (PRWEB) Jan. 29, 2018-Doctor Evidence collaborated on the underlying systematic review SANTA MONICA, Calif., Jan. 29, 2018 /PRNewswire/ — Today, the highly anticipated guidelines on screening for lung cancer by the American College of Chest Physicians® (CHEST) were published online on the journal CHEST® website. This comes after the guideline panelists provided a peek at the recommendations during […]

Read More